MicrosoftTeams-image (6)

Watch back this conversation where Prof Paresh Malhotra, Dr Fiona McLean and Henry Scowcroft discuss the protein amyloid.

You may have seen news stories over the last year that new treatments for Alzheimer's disease are targeting something called amyloid. Amyloid is one of the key proteins involved in Alzheimer's disease and has been the focus of lots of biomedical research for the past 30 years. However, amyloid is not the only focus for research.

The panel discuss how this tiny protein has shaped our understanding of Alzheimer’s disease and why is it important that we also look beyond amyloid for treatments for dementia.

The recording of this webinar is open to everyone, and no previous knowledge of dementia or research is required.

Follow the link to watch the recording of the event.

Play Video

Speakers

Prof Paresh Malhotra

Prof Paresh Malhotra is a neurologist, splitting his time between clinical and research work. He runs regular neurology clinics at Charing Cross Hospital, where he sees people with memory and thinking problems. His research at Imperial College London focusses on Alzheimer's disease and vascular dementia, working on areas like brain imaging to detect amyloid, as well as leading clinical trials.

Dr Fiona McLean
Henry Scowcroft

Dr Fiona McClean is a researcher working at the University of Dundee. Her research interests are on the links between diet, metabolism and brain diseases such as Alzheimer’s and other dementias. She is currently working on a project focussing on the blood-brain barrier, which is meant to protect the brain. She wants to understand if changes in metabolism cause this barrier to become leaky, and how this may contribute to the diseases that cause dementia.

Henry Scowcroft is Alzheimer’s Research UK’s head of communications. Born into a family of scientists, writers and medics, Henry is an experienced communications professional and science writer, with a Bachelor's degree in biochemistry and a Master's degree in Science Communication. He’s spent two decades working in a variety of roles across the medical research charity sector, all of which have centred around one thing: communicating complex, emotive and at times controversial issues to a variety of audiences, including patients, the public, journalists, policy-makers and supporters.

For more information or questions about the event, please email the Public Engagement team engage@alzheimersresearchuk.org

If you have accessibility requirements, please get in touch and we’ll do what we can to help you